🔗 Share this article

A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with thousands of members share comparison photos, administration instructions and claims of rapid UK delivery. Vendors market the substance there before directing customers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Several experts stated the popularity for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has removed violative material and prohibited associated keywords and query recommendations. The organization said it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Operations

Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, populated with images of weight loss, positive reviews and detailed guides for preparing or injecting at residence.

After moments of entering one group, a seller posted contact information, where the majority of transactions take place. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, health issues or past usage.

Product Details and Pricing

Inside these communities, messages show dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially significant health risks”.